ABSTRACT
Leiomyosarcoma with adipocytic differentiation or lipoleiomyosarcoma is an uncommon sarcoma of the female genital tract with only a few individual reports in the literature. We therefore performed a morphologic, immunohistochemical, MDM2 gene amplification and RNA and DNA sequencing analysis of a series of gynecologic lipoleiomyosarcoma to better define the clinicopathologic spectrum. Six tumors from 6 patients were identified and classified as spindled lipoleiomyosarcoma (n = 2), mixed spindled and myxoid lipoleiomyosarcoma (n = 1), epithelioid lipoleiomyosarcoma with focal myxoid features (n = 1) and mixed spindled and epithelioid lipoleiomyosarcoma (n = 2). Patient age ranged from 41 to 64 years (mean: 49; median: 50). Primary location included uterine corpus (3), uterine corpus/cervix (2) and broad ligament (1). Tumor size ranged from 4.5 to 22 cm (mean: 11.2; median: 9.8). Four patients had metastasis at presentation or subsequently developed recurrent or distant disease. Patient status was known for 5: 2 dead of disease, 2 alive with disease and 1 alive without evidence of disease. Immunohistochemical expression of smooth muscle markers, ER, PR and WT-1 showed patterns similar to non-adipocytic gynecologic leiomyosarcomas. MDM2 amplification fluorescence in situ hybridization performed on 2 tumors was negative in 1 and equivocal in 1. Sequencing studies performed on 3 tumors found TP53 mutations in 3, with 1 tumor also having an ATRX alteration. No gene fusions were identified. Although lipoleiomyosarcomas have a diverse morphologic spectrum, our findings suggest the smooth muscle component shares morphologic and immunohistochemical features with female genital tract non-adipocytic leiomyosarcomas. Lipoleiomyosarcomas also have genetic alterations associated with non-adipocytic gynecologic leiomyosarcomas.
Subject(s)
Leiomyosarcoma , Smooth Muscle Tumor , Humans , Female , Adult , Middle Aged , Leiomyosarcoma/pathology , Smooth Muscle Tumor/pathology , In Situ Hybridization, Fluorescence , Biomarkers, Tumor/genetics , Biomarkers, Tumor/analysis , Immunohistochemistry , Genitalia, Female/chemistry , Genitalia, Female/pathology , Molecular Biology , Proto-Oncogene Proteins c-mdm2/geneticsABSTRACT
Desmoplastic small round cell tumor (DSRCT) is a high-grade, primitive round cell sarcoma classically associated with prominent desmoplastic stroma, coexpression of keratin and desmin, and a characteristic EWSR1::WT1 gene fusion. DSRCT typically arises in the abdominopelvic cavity of young males with diffuse peritoneal spread and poor overall survival. Although originally considered to be pathognomonic for DSRCT, EWSR1::WT1 gene fusions have recently been detected in rare tumors lacking the characteristic morphologic and immunohistochemical features of DSRCT. Here, we report 3 additional cases of neoplasms other than conventional DSCRCT with EWSR1::WT1 gene fusions that occurred outside the female genital tract. Two occurred in the abdominopelvic cavities of a 27-year-old man and a 12-year-old girl, whereas the third arose in the axillary soft tissue of an 85-year-old man. All cases lacked prominent desmoplastic stroma and were instead solid and cystic with peripheral fibrous pseudocapsules and occasional intervening fibrous septa. Necrosis was either absent (1/3) or rare (2/3), and mitotic activity was low (<1 to 3 per 10 hpf). In immunohistochemical studies, there was expression of smooth muscle actin (3/3) and desmin (3/3), rare to focal reactivity for EMA (2/3), and variable expression of CK AE1/AE3 (1/3). Myogenin and MyoD1 were negative, and C-terminus-specific WT1 was positive in both cases tested (2/2). All 3 tumors followed a more indolent clinical course with 2 cases demonstrating no evidence of disease at 20 and 44 months after resection. The patient from case 3 died of other causes at 14 months with no evidence of recurrence. DNA methylation profiling showed that the 3 cases clustered with DSRCT; however, they demonstrated fewer copy number variations with 2 cases having a flat profile (0% copy number variation). Differential methylation analysis with hierarchical clustering further showed variation between the 3 cases and conventional DSRCT. Although further study is needed, our results, in addition to previous reports, suggest that EWSR1::WT1 gene fusions occur in rare and seemingly distinctive tumors other than conventional DSRCT with indolent behavior. Proper classification of these unusual soft tissue tumors with EWSR1::WT1 gene fusions requires direct correlation with tumor morphology and clinical behavior, which is essential to avoid overtreatment with aggressive chemotherapy.
Subject(s)
Desmoplastic Small Round Cell Tumor , Soft Tissue Neoplasms , Male , Humans , Female , Child , Aged, 80 and over , Adult , DNA Copy Number Variations , Desmoplastic Small Round Cell Tumor/genetics , Desmoplastic Small Round Cell Tumor/pathology , Desmin , Genitalia, Female/chemistry , Genitalia, Female/metabolism , Genitalia, Female/pathology , Oncogene Proteins, Fusion/analysis , RNA-Binding Protein EWS/genetics , RNA-Binding Protein EWS/metabolism , WT1 Proteins/geneticsABSTRACT
Insulin receptor substrate 2 (IRS2) participates in reproduction; however, the location and expression of IRS2 in the reproductive system of female mice is not clear. We used real-time quantitative polymerase chain reaction (RT-PCR), western blot and immunohistochemical staining to investigate the expression of IRS2 in the ovary, oviduct and uterus of female mice during the estrous cycle. We found that IRS2 was expressed in all reproductive organs of mouse and that the expression level changed with the estrous phases. The expression of IRS2 in reproductive organs was greatest during estrus.
Subject(s)
Estrous Cycle , Genitalia, Female , Insulin Receptor Substrate Proteins , Animals , Female , Mice , Energy Metabolism/genetics , Epithelial Cells/chemistry , Epithelial Cells/metabolism , Estrous Cycle/genetics , Estrous Cycle/metabolism , Gene Expression , Genitalia, Female/chemistry , Genitalia, Female/metabolism , Insulin Receptor Substrate Proteins/analysis , Insulin Receptor Substrate Proteins/genetics , Insulin Receptor Substrate Proteins/metabolismABSTRACT
Visualizing precise spatial patterns of an organ-wide gene and protein expression among diverse cell types can provide critical insights into the fundamental processes underlying normal tissue homeostasis and disease development. Here, we describe an optimized protocol for single-molecule RNA in situ hybridization (smRNA-ISH), immunohistochemistry, and cell lineage analysis of the female reproductive tract organs using commercially available smRNA-ISH probes, antibodies, and inducible Cre-mice. The high-resolution multispectral fluorescence imaging is performed using wide-field epifluorescence or confocal microscopy combined with a slide scanner. For complete details on the use and execution of this protocol, please refer to Chumduri et al. (2021).
Subject(s)
Genitalia, Female , Histocytochemistry/methods , Proteome/analysis , RNA , Animals , Female , Genitalia, Female/chemistry , Genitalia, Female/cytology , Genitalia, Female/metabolism , Image Processing, Computer-Assisted , Mice , Microscopy, Fluorescence , Organ Specificity/genetics , Organ Specificity/physiology , RNA/analysis , RNA/genetics , Transcriptome/geneticsABSTRACT
Single-cell RNA sequencing (scRNA-seq) is a powerful tool for enumerating the gene expression dynamics at single-cell resolution. Various organs comprising distinct cellular composition and architecture require unique approaches for highly viable single-cell preparation and reliable sequencing results. Here, we describe an optimized protocol for isolating the female reproductive tract (FRT), dissecting different FRT regions, and preparing high-viability single cells from the uterine endocervix and ectocervix to generate a complete molecular cell atlas by scRNA-seq for studying normal physiology and disease. For complete details on the use and execution of this protocol, please refer to Chumduri et al. (2021).
Subject(s)
Genitalia, Female , Molecular Imaging/methods , RNA-Seq/methods , Single-Cell Analysis/methods , Animals , Female , Genitalia, Female/chemistry , Genitalia, Female/cytology , Genitalia, Female/metabolism , Image Processing, Computer-Assisted , MiceABSTRACT
An alpine environment is unique due to pasture biodiversity, with an abundant content of natural antioxidant polyphenols. The present study investigated the effects of lowland and alpine grazing on the oviduct and uterine tissue redox status and amino acid concentrations in plasma and reproductive fluids. In the first experiment, heifers grazed on lowland (H-LOW: nâ¯=â¯13) and on alpine (H-ALP: nâ¯=â¯15) pastures. In the second experiment, heifers grazed on the same lowland (HS-LOW: nâ¯=â¯6) and on a different alpine (HS-ALP: nâ¯=â¯6) pasture. The abundance of mRNA transcripts for antioxidant enzymes in the oviduct (glutathione S-transferase alpha 2, glutathione synthetase (GSS)) and the endometrium (catalase, glutathione-disulfide reductase, GSS) was less (Pâ¯<⯠0.05), and for glutathione peroxidase 4 in the endometrium greater (Pâ¯=⯠0.006) in the H-LOW than in the H-ALP group. The abundance of mRNA transcript for catalase was less in the endometrium in the H-LOW than in the H-ALP (Pâ¯=⯠0.001) group. Catalase and NAD(P)H quinone dehydrogenase 1 concentrations in the oviduct were greater in the HS-LOW than in the HS-ALP group (Pâ¯<⯠0.05). Of 32 amino acids analysed, there were differences in concentrations in the H-LOW and H-ALP group of 13, seven and 15 in plasma, oviduct and uterine fluids, respectively (Pâ¯<⯠0.05). Comparing the HS-LOW to the HS-ALP groups, there were 13, one and three amino acids in the plasma, oviduct and uterine fluids, respectively, that were differentially abundant (Pâ¯<⯠0.05). The grazing systems had some effect on the redox status and amino acid patterns in reproductive tissues.
Subject(s)
Amino Acids/metabolism , Animal Husbandry , Cattle/physiology , Genitalia, Female/metabolism , Altitude , Amino Acids/chemistry , Animals , Female , Genitalia, Female/chemistry , Oxidation-ReductionABSTRACT
OBJECTIVES: Genital talc use is associated with increased risk for ovarian carcinoma in epidemiologic studies. Finding talc in pelvic tissues in women with ovarian carcinoma who have used talc is important in documenting exposure and assessing talc's biologic potential, but tissue-based morphology studies have been rarely reported. METHODS: We report five patient cases with documented perineal talc use, each of whom had talc (by both polarized light and scanning electron microscopy) in multiple pelvic sites distant from the perineum. Six negative-exposure control patients were also analyzed. RESULTS: Talc particles were found in exposed patients, typically within two or more of the following locations: pelvic region lymph nodes, cervix, uterine corpus, fallopian tubes, and ovaries. CONCLUSIONS: Our report adds new insights into the biologic potential of talc and suggests additional anatomic sites that should be closely examined for talc by oncologic surgical pathologists in the setting of perineal talc use.
Subject(s)
Genitalia, Female/metabolism , Ovarian Neoplasms/metabolism , Pelvis , Perineum , Talc/pharmacokinetics , Adenocarcinoma, Clear Cell/metabolism , Carcinoma, Endometrioid/metabolism , Cystadenocarcinoma, Serous/metabolism , Female , Genitalia, Female/chemistry , Humans , Lymph Nodes/chemistry , Lymph Nodes/metabolism , Microscopy, Electron, Scanning , Microscopy, Polarization , Middle Aged , Ovarian Neoplasms/chemically induced , Talc/adverse effects , Talc/analysis , Uterus/chemistry , Uterus/metabolismABSTRACT
Fibrinogen C domain containing 1 (FIBCD1) is a transmembrane receptor that binds chitin and other acetylated compounds with high affinity. FIBCD1 has previously been shown to be present in the epithelium of the gastrointestinal tract. In the present study, we performed a detailed analysis of normally structured human tissues for the expression of FIBCD1 by quantitative PCR and immunohistochemistry. We find that FIBCD1 is expressed in epithelial cells derived from all three germ layers. Endodermal-derived epithelial cells throughout the gastrointestinal tract and the respiratory system showed high expression of FIBCD1 and also mesodermal-derived cells in the genitourinary system and ectodermal-derived epidermis and sebaceous glands cells expressed FIBCD1. In some columnar epithelial cells, for example, in the salivary gland and gall bladder, the FIBCD1 expression was clearly polarized with strong apical reaction, while other columnar cells, for example, in small and large intestine and in bronchi, the staining was equally strong apically and basolaterally. In keratinocytes in skin, tongue, and oral cavity, the FIBCD1 staining was granular. This expression pattern together with the known binding properties supports that FIBCD1 plays a role in innate immunity in the skin and at mucosal surfaces.
Subject(s)
Epithelium/chemistry , Mucous Membrane/chemistry , Receptors, Cell Surface/analysis , Brain Chemistry , Epithelium/metabolism , Female , Gastrointestinal Tract/chemistry , Gastrointestinal Tract/metabolism , Gene Expression , Genitalia, Female/chemistry , Genitalia, Female/metabolism , Genitalia, Male/chemistry , Genitalia, Male/metabolism , HEK293 Cells , Humans , Immunohistochemistry , Male , Mucous Membrane/metabolism , RNA, Messenger/analysis , RNA, Messenger/genetics , Receptors, Cell Surface/genetics , Respiratory System/chemistry , Respiratory System/metabolism , Urinary Tract/chemistry , Urinary Tract/metabolismABSTRACT
The Syrian hamster, Mesocricetus auratus, is a suitable rodent species for standard regulatory toxicity studies. However, little is published about the female Syrian hamster reproductive system. It has unique anatomic features that differ from the other rodent species. In the hamster, the upper cervix is composed of 2 canals and the vagina shows 2 lateral pouches where keratin debris accumulates. These pouches must be distinguished from the vagina in order to stage the estrous cycle properly. The microscopic changes occurring during all the estrous cycle stages show some differences with the other rodents, the lower cervix and upper vagina presenting the more dramatic changes. The aim of this work was to produce a practical guide to staging the cycle and to highlight some of the differences between the rat and hamster reproductive system.
Subject(s)
Estrous Cycle/physiology , Genitalia, Female , Mesocricetus , Animals , Cricetinae , Female , Genitalia, Female/anatomy & histology , Genitalia, Female/chemistry , Genitalia, Female/physiology , Histological Techniques , Mesocricetus/anatomy & histology , Mesocricetus/physiology , Rats , Toxicity TestsABSTRACT
Determinants of HIV-infected women's genital tract mucosal immune health are not well understood. Because raltegravir (RAL) achieves relatively higher genital tract concentrations than ritonavir-boosted atazanavir (ATV), we examined whether an RAL-based regimen is associated with improved cervical immune reconstitution and less activation in HIV(+) women compared to an ATV-based regimen. Peripheral blood, cervical brushings, cervical-vaginal lavage (CVL), and cervical biopsies were collected from HIV(+) women on tenofovir disoproxil fumarate and emtricitabine (TDF/FTC) and either RAL (n=14) or ATV (n=19) with CD4(+) T cells>300 cells/mm(3) and HIV RNA<48 copies/ml. HLA-DR(+)CD38(+) T cells were measured in blood and cervical cells using flow cytometry, CD4(+) and CD8(+) T cells were quantified in cervical biopsies by immunofluorescent analysis, and HIV RNA (VL), ATV, and RAL concentrations were measured in CVL. In a linear regression model of log(CVL concentration) versus both log(plasma concentration) and treatment group, the RAL CVL level was 519% (95% CI: 133, 1,525%) higher than for ATV (p<0.001). Genital tract VL was undetectable in 90% of subjects and did not differ by regimen. There were no significant differences between groups in terms of cervical %HLA-DR(+)CD38(+)CD4(+) or CD8(+) T cells, CD4(+) or CD8(+) T cells/mm(2), or CD4:CD8 ratio. After adjusting for treatment time and group, the CVL:plasma drug ratio was not associated with the cervical CD4:CD8 ratio or immune activation (p>0.6). Despite significantly higher genital tract penetration of RAL compared to ATV, there were no significant differences in cervical immune activation or reconstitution between women on these regimens, suggesting both drug regimens achieve adequate genital tract levels to suppress virus replication.
Subject(s)
Anti-HIV Agents/pharmacokinetics , Antiretroviral Therapy, Highly Active/methods , Atazanavir Sulfate/pharmacokinetics , Genitalia, Female/chemistry , Genitalia, Female/pathology , HIV Infections/drug therapy , Raltegravir Potassium/pharmacokinetics , Adult , Anti-HIV Agents/administration & dosage , Atazanavir Sulfate/administration & dosage , Blood/immunology , Blood/virology , CD4 Lymphocyte Count , Female , HIV Infections/pathology , HIV Infections/virology , HIV-1/isolation & purification , Humans , Middle Aged , Raltegravir Potassium/administration & dosage , T-Lymphocyte Subsets/immunology , Treatment Outcome , Viral LoadABSTRACT
Toll-like receptors (TLRs) and b-defensins (BD) molecules are group of molecules that recognize various microbial components and play a crucial role in the activation of the innate immune system in vertebrate species. Although TLRs gene expression has been studied in various pig tissues, little is known about their expression in porcine reproductive tract. Concerning b-defensins genes, only BD1, 2 and 3 counterparts have been well studied in pigs' reproductive organs. The aim of this study was to investigate the expression pattern of both gene families in pigs' male and female reproductive organs, and embryos, as potential tool for further association studies in respect to immunity and disease resistance. RT-PCR analysis revealed that all of the examined TLR genes were expressed in the reproductive organs of male and female pigs, with TLR3 and TLR5 showing the higher levels and TLR9 the lowest, in all analyzed tissues. BD genes showed a different expression pattern in respect to the examined tissue. In embryos, TLR1 revealed high expression levels, while only BD3, BD108, and BD123 were found to be expressed.
Subject(s)
Defensins/genetics , Defensins/metabolism , Genitalia, Female/metabolism , Genitalia, Male/metabolism , Swine/genetics , Toll-Like Receptors/genetics , Toll-Like Receptors/metabolism , Animals , Defensins/analysis , Embryo, Mammalian , Female , Genitalia, Female/chemistry , Genitalia, Male/chemistry , Male , Organ Specificity , Real-Time Polymerase Chain Reaction , Toll-Like Receptors/analysisABSTRACT
Olfactory cues play an integral, albeit underappreciated, role in mediating vertebrate social and reproductive behaviour. These cues fluctuate with the signaller's hormonal condition, coincident with and informative about relevant aspects of its reproductive state, such as pubertal onset, change in season and, in females, timing of ovulation. Although pregnancy dramatically alters a female's endocrine profiles, which can be further influenced by fetal sex, the relationship between gestation and olfactory cues is poorly understood. We therefore examined the effects of pregnancy and fetal sex on volatile genital secretions in the ring-tailed lemur (Lemur catta), a strepsirrhine primate possessing complex olfactory mechanisms of reproductive signalling. While pregnant, dams altered and dampened their expression of volatile chemicals, with compound richness being particularly reduced in dams bearing sons. These changes were comparable in magnitude with other, published chemical differences among lemurs that are salient to conspecifics. Such olfactory 'signatures' of pregnancy may help guide social interactions, potentially promoting mother-infant recognition, reducing intragroup conflict or counteracting behavioural mechanisms of paternity confusion; cues that also advertise fetal sex may additionally facilitate differential sex allocation.
Subject(s)
Cues , Genitalia, Female/metabolism , Lemur/physiology , Odorants/analysis , Pregnancy/physiology , Animal Communication , Animals , Female , Genitalia, Female/chemistry , Male , Volatile Organic Compounds/analysisABSTRACT
A novel antimicrobial peptide, SRTAP-40 has been purified and characterized from sheep reproductive tract. The isolation procedure entailed acetic acid extraction, gel filtration chromatography, and HPLC. SRTAP-40 is composed of 40 amino acid residues with a MW of 4,820.47 Da from MALDI-TOF-MS. Its N-terminal sequence was AYVLDEPKP. SRTAP-40 cDNA was cloned by 3'-RACE. SRTAP-40 showed activity against E. coli Staphylococcus aureus, Streptococcus sp. and, Candida albicans with MIC values of 12, 12, 24, 6 µg/ml, respectively. By BLAST search, SRTAP-40 had no significant similarity to any known peptide.
Subject(s)
Anti-Infective Agents/chemistry , Anti-Infective Agents/isolation & purification , Antimicrobial Cationic Peptides/chemistry , Antimicrobial Cationic Peptides/isolation & purification , Genitalia, Female/chemistry , Sheep , Amino Acid Sequence , Animals , Anti-Infective Agents/pharmacology , Antimicrobial Cationic Peptides/genetics , Antimicrobial Cationic Peptides/pharmacology , Base Sequence , Candida albicans/drug effects , Erythrocytes/drug effects , Female , Hemolysis/drug effects , Microbial Sensitivity Tests , Molecular Sequence Data , RabbitsABSTRACT
Human epididymis protein 4 (HE4) has received major attention as a potential tumor marker in epithelial ovarian cancer; however, evidence of significant overexpression of HE4 in several other human cancers is expanding. To assess the possible limitations or benefits of HE4 in a clinical setting, this review aims to systematically outline published results of HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors. Our findings suggest scientific basis for a potential diagnostic ability of HE4 in gynecologic cancer and lung cancer, and further research is needed regarding other cancers. Yet, it is important to recognize that other malignancies can cause increased HE4 levels. Furthermore, attention should be paid to the influence of age and renal function on HE4 serum levels in future studies as well as in the clinic for proper interpretation of serum HE4 test results. Cancer Epidemiol Biomarkers Prev; 23(11); 2285-95. ©2014 AACR.
Subject(s)
Biomarkers, Tumor/analysis , Biomarkers, Tumor/blood , Neoplasms/blood , Neoplasms/chemistry , Proteins/analysis , Proteins/metabolism , Female , Genitalia, Female/chemistry , Genitalia, Male/chemistry , Healthy Volunteers , Humans , Male , Neoplasms/pathology , WAP Four-Disulfide Core Domain Protein 2ABSTRACT
BACKGROUND: It is not known if fluctuations in genital tract antiretroviral drug concentrations correlate with genital virus shedding in human immunodeficiency virus (HIV)-infected women on antiretroviral therapy (ART). METHODS: Among 20 HIV-infected women on ART (tenofovir [TFV], emtricitabine [FTC], and ritonavir-boosted atazanavir [ATV]) with suppressed plasma virus loads, blood and cervicovaginal samples collected twice weekly for 3 weeks were tested for antiretroviral concentrations, HIV-1 RNA, and proviral DNA. RESULTS: Cervicovaginal:plasma antiretroviral concentration ratios were highest for FTC (11.9, 95% confidence interval [CI], 8.66-16.3), then TFV (3.52, 95% CI, 2.27-5.48), and ATV (2.39, 95% CI, 1.69-3.38). Within- and between-person variations in plasma and genital antiretroviral concentrations were observed. Low amounts of genital HIV-1 RNA (<50 copies/mL) were detected in 45% of women at 16% of visits. Genital HIV-1 DNA was detected in 70% of women at 35% of visits. Genital virus detection was associated with higher concentrations of mucosal leukocytes but not with genital antiretroviral concentrations, menstrual cycle phase, bacterial vaginosis, genital bleeding, or plasma virus detection. CONCLUSIONS: Standard doses of ART achieved higher genital than plasma concentrations across the menstrual cycle. Therapeutic ART suppresses genital virus shedding throughout the menstrual cycle, even in the presence of factors reported to increase virus shedding.
Subject(s)
Anti-Retroviral Agents/administration & dosage , Genitalia, Female/chemistry , Genitalia, Female/virology , HIV Infections/virology , HIV-1/isolation & purification , Menstrual Cycle , Virus Shedding , Adenine/administration & dosage , Adenine/analogs & derivatives , Adenine/pharmacokinetics , Adult , Anti-Retroviral Agents/pharmacokinetics , DNA, Viral/genetics , DNA, Viral/isolation & purification , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Deoxycytidine/pharmacokinetics , Emtricitabine , Female , HIV Infections/drug therapy , Humans , Middle Aged , Organophosphonates/administration & dosage , Organophosphonates/pharmacokinetics , Plasma/chemistry , Plasma/virology , RNA, Viral/genetics , RNA, Viral/isolation & purification , Ritonavir/administration & dosage , Ritonavir/pharmacokinetics , Tenofovir , Viral LoadABSTRACT
The exposure of oral antiretroviral (ARV) drugs in the female genital tract (FGT) is variable and almost unpredictable. Identifying an efficient method to find compounds with high tissue penetration would streamline the development of regimens for both HIV preexposure prophylaxis and viral reservoir targeting. Here we describe the cheminformatics investigation of diverse drugs with known FGT penetration using cluster analysis and quantitative structure-activity relationships (QSAR) modeling. A literature search over the 1950-2012 period identified 58 compounds (including 21 ARVs and representing 13 drug classes) associated with their actual concentration data for cervical or vaginal tissue, or cervicovaginal fluid. Cluster analysis revealed significant trends in the penetrative ability for certain chemotypes. QSAR models to predict genital tract concentrations normalized to blood plasma concentrations were developed with two machine learning techniques utilizing drugs' molecular descriptors and pharmacokinetic parameters as inputs. The QSAR model with the highest predictive accuracy had R(2)test=0.47. High volume of distribution, high MRP1 substrate probability, and low MRP4 substrate probability were associated with FGT concentrations ≥1.5-fold plasma concentrations. However, due to the limited FGT data available, prediction performances of all models were low. Despite this limitation, we were able to support our findings by correctly predicting the penetration class of rilpivirine and dolutegravir. With more data to enrich the models, we believe these methods could potentially enhance the current approach of clinical testing.
Subject(s)
Anti-Retroviral Agents/chemistry , Anti-Retroviral Agents/pharmacokinetics , Genitalia, Female/drug effects , Genitalia, Female/physiology , Quantitative Structure-Activity Relationship , Administration, Oral , Anti-Retroviral Agents/administration & dosage , Artificial Intelligence , Bodily Secretions/chemistry , Female , Genitalia, Female/chemistry , Humans , Models, StatisticalABSTRACT
BACKGROUND: Surrogate markers of HIV-1 pre-exposure prophylaxis and microbicide efficacy are needed. One potential surrogate is the antiviral activity in cervicovaginal lavage (CVL) after exposure to candidate products. We measured CVL antiviral activity in women using oral or vaginal tenofovir-based pre-exposure prophylaxis and correlated activity with drug and immune mediator levels. METHODS: Inhibitory activity against HIV-1 and herpes simplex virus (HSV)-2 and concentrations of interleukin (IL)-1ß, IL-6, IL-8, interferon-γ, induced protein 10 (IP-10), macrophage inflammatory protein (MIP)-1α, MIP-3a, lactoferrin, secretory leukocyte protease inhibitor, and defensins were measured in CVL obtained from 60 women at baseline and after 6 weeks of a randomized sequence of oral and topical tenofovir. CVL tenofovir concentrations were measured by mass spectrometry. RESULTS: The number of women with CVL anti-HIV activity ≥ 90% increased significantly from 5.0% at baseline to 89.1% after daily use of 1% tenofovir gel (relative risk = 17.85, P < 0.001), but there was no increase after daily oral tenofovir. The CVL anti-HIV activity correlated with drug levels (Spearman correlation coefficient 0.64 after tenofovir gel; P < 0.001) but not with the concentrations of mucosal immune mediators. No increase in CVL anti-HSV activity was observed after either drug regimen, an observation consistent with the higher concentrations of tenofovir needed to inhibit HSV-2 infection. The CVL anti-HSV activity correlated with lactoferrin, defensins, IP-10, IL-8, and detectable levels of MIP-1α but not with drug levels. CONCLUSIONS: CVL may provide a surrogate for local but not systemic drug efficacy and a tool to better understand mucosal factors that modulate antiviral activity in genital tract secretions.
Subject(s)
Adenine/analogs & derivatives , Anti-HIV Agents/administration & dosage , Anti-HIV Agents/pharmacokinetics , Bodily Secretions/chemistry , Chemoprevention/methods , Genitalia, Female/chemistry , Organophosphonates/administration & dosage , Organophosphonates/pharmacokinetics , Adenine/administration & dosage , Adenine/analysis , Adenine/pharmacokinetics , Administration, Intravaginal , Administration, Oral , Adult , Anti-HIV Agents/analysis , Female , HIV-1/drug effects , Herpesvirus 2, Human/drug effects , Humans , Mass Spectrometry , Microbial Sensitivity Tests , Organophosphonates/analysis , TenofovirABSTRACT
In response to growing concerns that environmental chemicals may have adverse effects on human health by altering the endocrine system, the Endocrine Disruptor Screening Program (EDSP), under the auspices of the United States Environmental Protection Agency (U.S. EPA), recently instituted a Tier I battery of tests including a female pubertal assay. This assay requires dosing of female rats from postnatal day (PND) 22 through PND 42 (or 43), the period of pubertal development in the rat, to identify test articles that may have estrogenic or antiestrogenic effects, or may alter hormones or neurotransmitters. While certain landmarks in female rat reproductive development are published, little is published on the microscopic appearance of the female reproductive tract during prepubertal and pubertal development. In this study, reproductive tissues from three female Sprague-Dawley rats were collected each day from PND 20 through PND 50, such that tissues from a total of 93 rats were collected throughout the prepubertal and pubertal period. Tissues were formalin-fixed, trimmed, paraffin-embedded, sectioned at 5-µm thickness, and examined microscopically. The major histologic features of the female reproductive tract throughout this critical period were described in detail. This information will help pathologists interpret findings observed in female pubertal assays.
Subject(s)
Genitalia, Female/cytology , Genitalia, Female/growth & development , Sexual Maturation/physiology , Animals , Body Weight/physiology , Female , Genitalia, Female/chemistry , Organ Size/physiology , Rats , Rats, Sprague-Dawley , Toxicity Tests/standardsABSTRACT
In recent years, intensive attention has been put on improving reproductive performance of pigs. Several experiments aimed to identify markers associated with prolificacy, but this issue still remains open. In our study, we investigated associations between polymorphisms in IGF2, GNAS and MC4R genes with reproductive traits of Polish Landrace and Large White pigs. We did not find any significant associations for g. GNAS314T > 324C, IGF2 intron3-g.3072G > A or g. MC4R 1426G > A in Polish Landrace and Large White pigs. In the case of IGF2 intron3-g.3072G > A, this information is of great importance, because this marker is widely implemented in pigs breeding and previous experiments suggested its role in prolificacy of pigs. We also investigated expression of IGF2 gene and showed that this gene is monoallelically expressed in reproductive organs (ovary and cornus uteri).
Subject(s)
GTP-Binding Protein alpha Subunits, Gs/genetics , Genitalia, Female/chemistry , Insulin-Like Growth Factor II/genetics , Receptor, Melanocortin, Type 4/genetics , Reproduction/genetics , Sus scrofa/genetics , Animals , Female , Gene Expression , Genomic Imprinting , Genotype , Ovary/chemistry , Polymorphism, Genetic , Sus scrofa/physiology , Uterus/chemistryABSTRACT
The aim of this experiment was to localize the mRNA and protein of ghrelin and its active receptor, growth hormone secretagogue 1A (GHS-R1A), within the reproductive tract of dairy cattle. Ghrelin is an orexigenic hormone that has been identified as a potent regulator of energy homeostasis. Recent evidence suggests that ghrelin may also serve as a metabolic signal to the reproductive tract. Ghrelin and GHS-R1A have been identified in the reproductive tract of several species, including humans, mice, and rats. However, ghrelin and GHS-R1A expression have not been described within bovine reproductive tissues. Therefore, the ampulla, isthmus, uterine body, corpus luteum, and follicles were harvested from 3 Holstein heifers (15.91±0.07 mo of age) immediately following exsanguination. Duodenum and hypothalamus were collected as positive controls for ghrelin and GHS-R1A, respectively. Tissues were fixed in 10% formalin and embedded in paraffin for microscopy. Additional samples were stored at -80°C for detection of mRNA. Ghrelin and GHS-R1A mRNA and protein were observed in all tissue types within the reproductive tract of dairy heifers; however, expression appeared to be cell specific. Furthermore, ghrelin protein appeared to be localized to the cytoplasm, whereas GHS-R1A protein was found on the plasma membrane. Within the reproductive tissues, ghrelin mRNA and protein were most abundantly expressed in the ampulla of the oviduct. Concentrations of GHS-R1A were lower than those of ghrelin but differed between tissues. This is one of the first studies to provide molecular evidence for the presence of ghrelin and GHS-R1A within the entire reproductive tract. However, implications for fertility remain to be determined.